Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease (Q37684572)
Jump to navigation
Jump to search
scientific article published on 05 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease |
scientific article published on 05 January 2010 |
Statements
1 reference
Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease (English)
1 reference
Lisa S Smith
1 reference
Michael Nelson
1 reference
Christian R Dolder
1 reference
5 January 2010
1 reference
1 reference
44
1 reference
2
1 reference
333-342
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference